TMCnet News
Bharat Book Bureau: PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update(M2 PressWIRE Via Acquire Media NewsEdge) Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently, trivalent intramuscular vaccines such as Sanofi's Fluzone and Vaxigrip, GlaxoSmithKline's Fluarix and FluLaval and Novartis' Fluvirin garner the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZeneca's intranasal FluMist and Sanofi's Fluzone IntraDermal, GlobalData projects a dramatic shift favoring the adoption of such vaccines over the traditional intramuscular vaccines. GlobalData also anticipates that manufacturers that launch quadrivalent formulations will steal market share, patient share, and revenue from the trivalent influenza vaccines currently available. Highlights Key Questions Answered - How big an impact will quadrivalent vaccines have on the seasonal influenza market? What do key opinion leaders think of this paradigm shift? - What are the key vaccines for each segment in the population? - Will vaccines with novel routes of administration face adoption challenges in the market? What is the projected uptake of intranasal FluMist or intradermal vaccines, like Fluzone IntraDermal, over the forecast period? - The developmental pipeline consists of cell culture based vaccines. Which of these vaccines will attain high sales revenues during 2012-2022 and in which markets? - What governmental and industry changes are likely to change the vaccination rates in the markets researched? Which is the biggest growth market globally? For more info: https://www.bharatbook.com/healthcare-market-research-reports-470144/drug-healthcare-global-15.html Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Email: [email protected] Website: www.bharatbook.com Follow us on twitter: https://twitter.com/researchbook Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau Our Blog : http://blog.bharatbook.com/ . (c) 2014 M2 COMMUNICATIONS [ Back To TMCnet.com's Homepage ] |